Mukul Mehta

Chief Financial Officer · Novartis

Pharmaceuticals

Mukul Mehta is Novartis’s chief financial officer. His career includes industrial and banking experience in India followed by country, divisional and corporate finance leadership across Novartis.

Last reviewed: Nov 15, 2026

Executive Summary

Mukul Mehta is Novartis’s chief financial officer. His career includes industrial and banking experience in India followed by country, divisional and corporate finance leadership across Novartis.

Career Highlights

  • Became group CFO on March 16, 2026.
  • Previously led finance for International, Pharmaceuticals and Business Services.
  • Joined Novartis’s finance development program in 2003.

Professional Journey

Mehta’s early career included manufacturing at Jindal Iron & Steel, banking operations at Standard Chartered and sales and marketing at Deutsche Bank in India. His education includes electrical engineering at PEC Chandigarh, management studies at JBIMS and an INSEAD MBA.

He joined Novartis’s finance development program in 2003. His early company roles included financial reporting and accounting in the Czech Republic and country CFO assignments in Norway and Poland. From 2011 he headed finance for global marketing and development.

He became country CFO in France in 2014, followed by European Pharmaceuticals finance, Business Services CFO and Pharmaceuticals CFO roles. From 2022 to 2025 he was CFO of International.

Mehta subsequently headed Business Planning & Analysis, Digital Finance and Tax. Novartis announced him as Harry Kirsch’s successor in July 2025, with the transition scheduled for March 2026. His current biography confirms that he became group CFO on March 16, 2026.

Education

Master of Business Administration — INSEAD.

Master of Management Studies — JBIMS.

Bachelor of Engineering — PEC Chandigarh — Electrical Engineering.